Who We Are
Who We Are
Since our inception, we have been committed to identifying and maximizing opportunities to develop and commercialize first-in-class, plant-based prescription medicines.
From Tree to Patient
We are focused on leveraging our broad intellectual property portfolio, our robust and far-reaching pipeline, and our extensive botanical library to develop breakthrough remedies to serve the unmet medical needs of people around the globe.
From Tree to Patient
We are focused on leveraging our broad intellectual property portfolio, our robust and far-reaching pipeline, and our extensive botanical library to develop breakthrough remedies to serve the unmet medical needs of people around the globe.
The Jaguar Health Family of Companies
Jaguar Health’s organizational framework is designed to enable our product pipeline to reach the world’s interconnected marketplace, allowing for development and commercialization opportunities worldwide.
Jaguar family companies Napo Pharmaceuticals, Inc. and Napo Therapeutics S.p.A. focus on the development and commercialization of our novel crofelemer powder for oral solution for the treatment of rare and orphan adult and pediatric gastrointestinal disorders, including microvillus inclusion disease (MVID) and short bowel syndrome with intestinal failure (SBS-IF).
Our Social Responsibility
At Jaguar Health, we prioritize our impact on environmental and social issues. Our focus includes sustainability, community benefit sharing, and recognizing and honoring the wisdom and expertise of the Indigenous healers who first discovered the medicinal properties of specific plants.
Our Social Responsibility
At Jaguar Health, we prioritize our impact on environmental and social issues. Our focus includes sustainability, community benefit sharing, and recognizing and honoring the wisdom and expertise of the Indigenous healers who first discovered the medicinal properties of specific plants.
